Penumbra Coil 400 4006U0408Recalls & reported problems
Penumbra, Inc. · PC400 Curve Sft, 4x8 · Class 2 · Implant
All models of Penumbra Coil 400 (120)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M4244006U04080), received between Sep 30, 2015 and Feb 5, 2022 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Kinked” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Kinked1
- Physical Resistance/Sticking1
- Premature Separation1
Patient problems
- Infarction, Cerebral1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 5, 2022Physical Resistance/Sticking; Premature Separation; Physical Resistance/Sticking; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE INTERNAL CAROTID ARTERY (ICA) USING PENUMBRA COIL 400S (PC400S), A PX SLIM DELIVERY MICROCATHETER (PX SLIM), A NEURON MAX 6F 088 LONG SHEATH (NEURON MAX), AND A NEURON DELIVERY CATHETER 070 (NEURON 070). DURING THE PROCEDURE, THE PHYSICIAN ADVANCED A NEURON 070 THROUGH THE NEURON MAX TO THE TARGET VESSEL AND THEN ADVANCED THE PX SLIM THROUGH THE NEURON 070 TO THE TARGET VESSEL. NEXT, WHILE ADVANCING A PC400 INTO THE TARGET VESSEL USING THE PX SLIM, THE PHYSICIAN EXPERIENCED RESISTANCE AND SUBSEQUENTLY THE PC400 UNINTENTIONALLY DETACHED AND MIGRATED INTO THE MIDDLE CEREBRAL ARTERY (MCA). THEREFORE, THE PHYSICIAN USED A SNARE DEVICE TO REMOVE THE DETACHED PC400. AFTERWARDS, WHILE ADVANCING A NEW PC400 THROUGH THE PX SLIM, THE PHYSICIAN EXPERIENCED RESISTANCE AND SUBSEQUENTLY THE PC400 UNINTENTIONALLY DETACHED WITH APPROXIMATELY HALF OF THE PC400 IN THE PX SLIM AND THE OTHER HALF IN THE TARGET VESSEL. THEREFORE, THE PX SLIM CONTAINING THE DETACHED PC400 WAS REMOVED. THE PROCEDURE WAS COMPLETED USING OTHER COILS, ANOTHER MICROCATHETER, THE SAME NEURON MAX, AND THE SAME NEURON 070. THERE WAS NO REPORT OF AN ADVERSE EFFECT T
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13467141 ↗MalfunctionApr 18, 2016Kinked; Kinked
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE USING PENUMBRA COIL 400 COILS (PC400 COILS). DURING THE PROCEDURE, WHILE ADVANCING A PC400 COIL THROUGH THE PX SLIM DELIVERY MICROCATHETER (PX SLIM), THE TECHNICIAN KINKED THE PC400 COIL PUSHER ASSEMBLY. THEREFORE, THE PHYSICIAN REMOVED BOTH THE PC400 COIL AND THE PX SLIM FROM THE PATIENT AND THEN DECIDED TO DOWNSIZE HIS SYSTEM. THERE WERE NO REPORTED ISSUES WITH THE PX SLIM. THE PROCEDURE WAS COMPLETED USING A NEW PC400 COIL AND A NEW MICROCATHETER FROM ANOTHER MANUFACTURER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5585755 ↗InjurySep 30, 2015Adverse Event Without Identified Device or Use Problem
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION IN THE ANTERIOR CEREBRAL ARTERY (ACA)-ANTERIOR COMMUNICATING ARTERY USING PENUMBRA COIL 400 COILS (PC400 COILS). DURING THE PROCEDURE, THIRTEEN PC400 COILS WERE SUCCESSFULLY DEPLOYED AND DETACHED INTO THE ANEURYSM WITH NO COMPLICATIONS. APPROXIMATELY 3 MONTHS POST-PROCEDURE, THE PATIENT EXPERIENCED A SEVERE ISCHEMIC STROKE IN THE LEFT ANTERIOR CEREBRAL ARTERY. CORONARY COMPUTED TOMOGRAPHY ANGIOGRAM (CTA), MAGNETIC RESONANCE IMAGING (MRI), ELECTROENCEPHALOGRAM (EEG), TRANSTHORACIC ECHOCARDIOGRAM (TTE) WERE PERFORMED AND THE PATIENT WAS TREATED WITH SIMVASTATIN. THE REPORTED ISCHEMIC STROKE RESOLVED ON (B)(6) 2013.
Patient problems: Infarction, Cerebral
MAUDE report 5114284 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page